JEFFREY KRAFT: Open Payments
NPI 1346221785 · WARREN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 110 payments from 17 companies in 2025. Trend: 2023 $1,702 · 2024 $1,952 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $723 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $396 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $275 |
| Novo Nordisk Inc | 16 | $250 |
| GlaxoSmithKline, LLC. | 14 | $202 |
| Abbott Laboratories | 13 | $197 |
| Corcept Therapeutics | 4 | $97 |
| PFIZER INC. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Amgen Inc. | 3 | $54 |
Products named: Kerendia, JARDIANCE, BREZTRI, FREESTYLE LIBRE 3, AIRSUPRA, TRELEGY ELLIPTA, FARXIGA, Korlym.
Industry payments across MI — which companies pay providers there.
